Prenatal Diagnosis of Rubinstein‐Taybi Syndrome—Reporting Twelve Cases of a Rare Disease
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Qiu-Xia Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Rubinstein-Taybi Syndrome, Rare Diseases. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Guangzhou Science, Technology and Innovation Commission.
Abstract (Originalsprache)
Objective
To present the prenatal sonographic features and genomic spectrum of pregnancies with fetal Rubinstein‐Taybi syndrome (RSTS).
Methods
This was a retrospective study of 12 cases with RSTS with fetal features identified by prenatal ultrasound and confirmed by genetic testing. Chromosomal microarray analysis utilizing an Affymetrix CytoScan 750k SNP array was employed to detect pathogenic copy number variations (CNVs). Trio exome sequencing was used to detect monogenic conditions. Clinical and laboratory data were collected and reviewed for these cases, including maternal demographics, prenatal sonographic findings, molecular testing sequencing results, and pregnancy outcomes.
Results
All cases had unremarkable first‐trimester ultrasound scans without reporting limb malformations. Seven cases presented with abnormal second‐trimester ultrasounds: three instances of cardiac defects, two instances of limb abnormalities (one with short long bones and one with duplication of big toes), one case of intracranial malformation (dysgenesis of the corpus callosum), and one instance of restricted fetal growth. Five pregnancies exhibited abnormal sonographic signs in the third trimester: two cases of restricted fetal growth, one with clubfeet and polyhydramnios, one with hypospadias, and one with isolated polyhydramnios. CNVs involving CREBBP deletions were detected in two cases. Variants were identified in two genes: CREBBP in six instances and EP300 in four instances; all CNVs or variants were de novo.
Conclusion
Our results underscore the challenges faced in the prenatal detection of RSTS due to the lack of specific clinical presentations. Our study highlights that even nonspecific findings on prenatal ultrasound may justify exome sequencing, enabling timely potential genetic diagnoses and improving clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Dong-Zhi Li
Förderung
- Guangzhou Science, Technology and Innovation Commission
Zitieren
APA
Yu, Q. X., Jing, X. Y., Xiao, Z. Q., Li, S. Y., Zhen, L., & Li, D. Z. (2025). Prenatal Diagnosis of Rubinstein‐Taybi Syndrome—Reporting Twelve Cases of a Rare Disease. Prenatal Diagnosis. https://doi.org/10.1002/pd.70009
Vancouver
Yu QX, Jing XY, Xiao ZQ, Li SY, Zhen L, Li DZ. Prenatal Diagnosis of Rubinstein‐Taybi Syndrome—Reporting Twelve Cases of a Rare Disease. Prenatal Diagnosis. 2025. doi:10.1002/pd.70009
BibTeX
@article{Yu2025,
author = {Yu, Qiu-Xia and Jing, Xiang-Yi and Xiao, Zhi-Qing and Li, Si-Yun and Zhen, Li and Li, Dong-Zhi},
title = {Prenatal Diagnosis of Rubinstein‐Taybi Syndrome—Reporting Twelve Cases of a Rare Disease},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.70009}
}
EUVIMED